omalizumab [Omalizumab]
- Termíny
-
Xolair
-
Xolair
An anti-IgE, recombinant, humanized monoclonal antibody which specifically binds to the C epsilon3 domain of IMMUNOGLOBULIN E, the site of high-affinity IgE receptor binding. It inhibits the binding of IgE to MAST CELLS and BASOPHILS to reduce the severity of the allergic response and is used in the management of persistent allergic ASTHMA.
- DUI
- D000069444 MeSH Prohlížeč
- CUI
- M0387411
- CAS
- Immunoglobulin G, anti-(human immunoglobulin E Fc region)(human-mouse monoclonal E25 clone pSVIE26 gamma-chain), disulfide with human-mouse monoclonal E25 clone pSVIE26 kappa-chain, dimer
- Historická pozn.
- 2016 (2001)
- Veřejná pozn.
- 2016; OMALIZUMAB was indexed under ANTIBODIES, ANTI-IDIOTYPIC and ANTIBODIES, MONOCLONAL, HUMANIZED 2011-2015; and under ANTIBODIES, MONOCLONAL 2001-2011
Povolená podhesla
- AN
- analýza 0
- AD
- aplikace a dávkování 33
- BI
- biosyntéza 0
- CH
- chemie 0
- HI
- dějiny 0
- EC
- ekonomika 5
- PK
- farmakokinetika 0
- PD
- farmakologie 28
- PH
- fyziologie 0
- GE
- genetika 0
- IM
- imunologie 1
- IP
- izolace a purifikace 0
- CL
- klasifikace 0
- BL
- krev 0
- ME
- metabolismus 0
- UR
- moč 0
- CF
- mozkomíšní mok 0
- PO
- otrava 0
- AE
- škodlivé účinky 13
- TU
- terapeutické užití 76
- TO
- toxicita 0
- DE
- účinky léků 0
- RE
- účinky záření 0
- UL
- ultrastruktura 0